SOX1 autoantibodies are serological markers of small cell lung cancer (SCLC).They occur in up to 15% of patients with SCLC independently of the presence of a paraneoplastic neurological syndrome (PNS) (1, 2). Here, SOX1 is linked to paraneoplastic neurologic syndrome.